Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Pacific Health Care Organization (PFHO) Net Income towards Common Stockholders (2016 - 2025)

Pacific Health Care Organization's Net Income towards Common Stockholders history spans 16 years, with the latest figure at $235075.0 for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 20.52% year-over-year to $235075.0; the TTM value through Dec 2025 reached $1.4 million, up 57.05%, while the annual FY2025 figure was $1.4 million, 57.05% up from the prior year.
  • Net Income towards Common Stockholders reached $235075.0 in Q4 2025 per PFHO's latest filing, up from $223002.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $636907.0 in Q2 2025 to a low of $61019.0 in Q4 2022.
  • Average Net Income towards Common Stockholders over 5 years is $231728.6, with a median of $194704.0 recorded in 2022.
  • Peak YoY movement for Net Income towards Common Stockholders: skyrocketed 312.0% in 2021, then crashed 84.93% in 2022.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $405037.0 in 2021, then plummeted by 84.93% to $61019.0 in 2022, then soared by 271.56% to $226721.0 in 2023, then soared by 30.45% to $295762.0 in 2024, then fell by 20.52% to $235075.0 in 2025.
  • Per Business Quant, the three most recent readings for PFHO's Net Income towards Common Stockholders are $235075.0 (Q4 2025), $223002.0 (Q3 2025), and $636907.0 (Q2 2025).